Tumor-suppressive activity of CD66a in prostate cancer

Cancer Gene Therapy

Volumn 6, Issue 4, 1999, Pages 313-321

  Luo, Weiping ^a   Tapolsky, Mary ^b   Earley, Karen ^a   Wood, Christopher G ^a   Wilson, Deborah R ^b   Logothetis, Christopher J ^a   Lin, Sue Hwa ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Introgen Therapeutics Inc   (United States)

Author keywords

Adenovirus; Cell adhesion molecule; Gene therapy; Prostate cancer; Tumor suppressor

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CD66 ANTIGENS; CEACAM1 PROTEIN, MOUSE; CELL ADHESION MOLECULE; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; MESSENGER RNA; PRIMER DNA;

ADENOVIRUS; ANIMAL; ARTICLE; CELL ADHESION; CELL CULTURE; GENE THERAPY; GENETICS; HUMAN; MALE; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; PATHOLOGY; PROSTATE TUMOR; RAT; TRANSGENE;

ADENOVIRIDAE; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; BASE SEQUENCE; CARCINOEMBRYONIC ANTIGEN; CELL ADHESION; CELL ADHESION MOLECULES; DNA PRIMERS; GENE THERAPY; HUMANS; MALE; MICE; PROSTATIC NEOPLASMS; RATS; RNA, MESSENGER; TRANSGENES; TUMOR CELLS, CULTURED;

EID: 0033159137     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700055     Document Type: Article

References (39)

1. Hsieh JT, Lin SH. Androgen regulation of cell adhesion molecule gene expression in rat prostate during organ degeneration: C-CAM belongs to a class of androgenrepressed genes associated with enriched stem/amplifying cell population after prolonged castration. J Biol Chem. 1994;269:3711-3716.
2. Hsieh JT, Luo W, Song W, et al. Tumor-suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches. Cancer Res. 1995;55:190-197.
3. Kunath T, Ordonez-Garcia C, Turbide C, Beauchemin N. Inhibition of colonic tumor cell growth by biliary glycoprotein. Oncogene. 1995;11:2375-2382.
4. Kleinerman DI, Zhang WW, Lin SH, Nguyen TV, von Eschenbach AC, Hsieh JT. Application of a tumor suppressor (C-CAM1)-expressing recombinant adenovirus in androgen-independent human prostate cancer therapy: a preclinical study. Cancer Res. 1995;55:2831-2836.
5. Tripathy SK, Black HB, Goldwasser E, Leiden JM. Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replicationdefective adenovirus vectors. Nat Med. 1996;2:545-550.
6. Takahashi H, Okai Y, Paxton RJ, Hefta LJ, Shively, JE. Differential regulation of carcinoembryonic antigen and biliary glycoprotein by γ-interferon. Cancer Res. 1993;53: 1612-1619.
7. Melton DA, Krieg PA, Rebagaliati MR, Maniatis T, Zinn K, Green MR. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 1984;12:7035-7056.
8. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
9. Hinoda Y, Neumaier M, Hefta SA. Molecular cloning of a cDNA coding biliary glycoprotein I: primary structure of a glycoprotein immunologically crossreactive with carcinoembryonic antigen [published correction appears in Proc Natl Acad Sci USA. 1989;86:1668]. Proc Natl Acad Sci USA. 1988;86:6959-6963.
10. Barnett TR, Drake L, Pickle WD. Human biliary glycoprotein gene: characterization of a family of novel alternatively spliced RNAs and their expressed proteins. Mol Cell Biol. 1993;13:1273-1282.
11. Zhang W-W, Fang X, Branch CD, Mazur W, French BA, Roth JA. Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis. Bio Techniques. 1993;15:869-872.
12. Graham FL, Prevec L. Manipulation of adenovirus vectors. In: Murray EJ, Walker JM, eds. Methods in Molecular Biology, Vol. 7. Clifton, NJ: The Humana Press, 1991:109-128.
13. Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem. 1977;83:346-356.
14. Rockwell SC, Kallman RF, Fajardo LF. Characteristics ofa serially transplanted mouse mammary tumor and its tissueculture-adapted derivative. J Natl Cancer Inst. 1972;49: 735-749.
15. Horoszewicz JS, Leong SS, Kawinski E, et al. LNCaP model of human prostatic carcinoma. Cancer Res. 1983;43: 1809-1818.
16. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF. Isolation of a human prostate carcinoma cell line (DU145). Int J Cancer. 1978;21:274-281.
17. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol. 1979;17:16-23.
18. Chen C-J, Lin T-T, Shively JE. Role of interferon regulatory factor-1 in the induction of biliary glycoprotein (cell CAM-1) by interferon-γ. J Biol Chem. 1996;271:28181-28188.
19. Kleinerman DI, Troncoso P, Lin SH, et al. Consistent expression of an epithelial cell adhesion molecule (C-CAM) during human prostate development and loss of expression in prostate cancer: implication as a tumor suppressor. Cancer Res. 1995;55:1215-1220.
20. 2+-dependent intercellular adhesion molecule. Cell Growth Differ. 1990;1:527-533.
21. Drzeniek Z, Lamerz R, Fenger U, Wagener C, Haubeck H-D. Identification of membrane antigen in granulocytes and colonic carcinoma cells by a monoclonal antibody specific for biliary glycoprotein, a member of the carcinoembryonic antigen family. Cancer Lett. 1991;56:173-179.
22. Cheung PH, Thompson NL, Earley K, Culic O, Hixson D, Lin SH. Cell-CAM105 isoforms with different adhesion functions are coexpressed in adult rat tissues and during liver development. J Biol Chem. 1993;268:6139-6146.
23. Thompson NL, Panzica MA, Hull G, et al. Spatiotemporal expression of two cell-cell adhesion molecule 105 isoforms during liver development. Cell Growth Differ. 1993;4:257-268.
24. Odin P, Asplund M, Busch C, Obrink B. Immunohistochemical localization of cellCAM 105 in rat platelets and granulocytes. J Histochem Cytochem. 1988;36:729-739.
25. Hixson DC, McEntire KD, Obrink B. Alterations in the expression of a hepatocyte cell adhesion molecule by transplantable rat hepatocellular carcinomas. Cancer Res. 1985;45:3742-3749.
26. Hixson DC, McEntire KD. Detection of an altered form of cell-CAM 105 on rat transplantable and primary hepatocellular carcinomas. Cancer Res. 1989;49:6788-6794.
27. Thompson NL, Lin SH, Panzica MA, Hixson DC. Cell CAM 105 isoform RNA expression is differentially regulated during rat liver regeneration and carcinogenesis. Pathobiology. 1994;62:209-220.
28. Becker A, Neumeier R, Park C, Gossrau R, Reutter W. Identification of a transformation-sensitive 110-kDa plasma membrane glycoprotein of rat hepatocytes. Eur J Cell Biol. 1985:39:417-423.
29. Rosenberg M, Nedellec P, Jothy S, Fleiszer D, Turbide C, Beauchemin N. The expression of mouse biliary glycoprotein, a carcinoembryonic antigen-related gene, is downregulated in malignant mouse tissues. Cancer Res. 1993;53: 4938-4945.
30. Neumaier M, Paululat S, Chan A, Matthaes P, Wagener C. Biliary glycoprotein, a potential human cell adhesion molecule, is down-regulated in colorectal carcinomas. Proc Natl Acad Sci USA. 1993;90:10744-10748.
31. Graff JR, Herman JG, Lapidus RG, et al. E-cadherinexpression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res. 1995;55:5195-5199.
32. Najjar SM, Boisclair YR, Nabih ZT, et al. Cloning and characterization of a functional promoter of the rat pp120 gene, encoding a substrate of the insulin receptor tyrosine kinase. J Biol Chem. 1996;271:8809-8817.
33. Hauck W, Nedellec P, Turbide C, Stanners CP, Barnett TR, Beauchemin N. Transcriptional control of the human biliary glycoprotein gene, a CEA gene family member down-regulated in colorectal carcinomas. Eur J Biochem. 1994;233:529-541.
34. Nedellec P, Turbide C, Beauchemin N. Characterization and transcriptional activity of the mouse biliary glycoprotein 1 gene, a carcinoembryonic antigen-related gene. Eur J Biochem. 1995;231:104-114.
35. Isaacs WB, Carter BS, Ewing CM. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res. 1991;51:4716-4720.
36. Bookstein R, Shew J-Y, Chen P-L, Scully P, Lee W-H. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science. 1990;247:712-715.
37. Clayman GL, El-Naggar AK, Lippman SM. Adenovirusmediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J Clin Oncol. 1998;16:2221-2232.
38. Cusack JC, Spitz FR, Nguyen D, Zhang W-W, Cristiano RJ, Roth JA. High levels of gene transduction in human lung tumors following intralesional injection of recombinant adenovirus. Cancer Gene Ther. 1996;3: 245-249.
39. Favrot M, Coll JL, Louis N, Negoescu A. Cell death and cancer-replacement of apoptotic genes and inactivation of death suppressor genes in therapy. Gene Ther. 1998;5:728-739.